Dr Reddy's, RDIF commence clinical trials for Sputnik vaccine
Dr Reddy’s, RDIF commence clinical trials for Sputnik vaccine
Dr Reddy's Laboratories Ltd and the Russian Direct Investment Fund (RDIF) on Tuesday announced commencement of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory, Kasauli in Himachal Pradesh.
Next Story
